Whole genome sequencing-based analysis of tuberculosis (TB) in migrants: rapid tools for cross-border surveillance and to distinguish between recent transmission in the host country and new importations.


Journal

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452

Informations de publication

Date de publication:
Jan 2019
Historique:
entrez: 31 1 2019
pubmed: 31 1 2019
medline: 28 7 2020
Statut: ppublish

Résumé

BackgroundThe analysis of transmission of tuberculosis (TB) is challenging in areas with a large migrant population. Standard genotyping may fail to differentiate transmission within the host country from new importations, which is key from an epidemiological perspective.AimTo propose a new strategy to simplify and optimise cross-border surveillance of tuberculosis and to distinguish between recent transmission in the host country and new importationsMethodsWe selected 10 clusters, defined by 24-locus mycobacterial interspersed repetitive unit-variable number tandem repeat (MIRU-VNTR), from a population in Spain rich in migrants from eastern Europe, north Africa and west Africa and reanalysed 66 isolates by whole-genome sequencing (WGS). A multiplex-allele-specific PCR was designed to target strain-specific marker single nucleotide polymorphisms (SNPs), identified from WGS data, to optimise the surveillance of the most complex cluster.ResultsIn five of 10 clusters not all isolates showed the short genetic distances expected for recent transmission and revealed a higher number of SNPs, thus suggesting independent importations of prevalent strains in the country of origin. In the most complex cluster, rich in Moroccan cases, a multiplex allele-specific oligonucleotide-PCR (ASO-PCR) targeting the marker SNPs for the transmission subcluster enabled us to prospectively identify new secondary cases. The ASO-PCR-based strategy was transferred and applied in Morocco, demonstrating that the strain was prevalent in the country.ConclusionWe provide a new model for optimising the analysis of cross-border surveillance of TB transmission in the scenario of global migration.

Identifiants

pubmed: 30696526
doi: 10.2807/1560-7917.ES.2019.24.4.1800005
pmc: PMC6351995
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

J Clin Microbiol. 2001 Mar;39(3):855-61
pubmed: 11230395
J Clin Microbiol. 2004 Jul;42(7):2952-60
pubmed: 15243044
J Clin Microbiol. 2006 Dec;44(12):4498-510
pubmed: 17005759
Clin Infect Dis. 2008 Jul 1;47(1):8-14
pubmed: 18484876
Clin Microbiol Infect. 2009 May;15(5):435-42
pubmed: 19416291
J Clin Microbiol. 2009 Jul;47(7):2026-32
pubmed: 19458183
N Engl J Med. 2011 Feb 24;364(8):730-9
pubmed: 21345102
Clin Microbiol Infect. 2013 Mar;19(3):292-7
pubmed: 22404140
J Clin Microbiol. 2012 Aug;50(8):2660-7
pubmed: 22675129
PLoS One. 2012;7(7):e41253
pubmed: 22911768
PLoS One. 2012;7(10):e47113
pubmed: 23077552
Lancet Infect Dis. 2013 Feb;13(2):137-46
pubmed: 23158499
PLoS Med. 2013;10(2):e1001387
pubmed: 23424287
Clin Microbiol Infect. 2013 Sep;19(9):796-802
pubmed: 23432709
BMC Infect Dis. 2013 Feb 27;13:110
pubmed: 23446317
Infect Genet Evol. 2014 Jan;21:463-71
pubmed: 23732366
J Infect Dis. 2014 Jan 1;209(1):98-108
pubmed: 23945373
Nat Genet. 2013 Oct;45(10):1176-82
pubmed: 23995134
Lancet Infect Dis. 2014 May;14(5):406-15
pubmed: 24602842
Euro Surveill. 2014 Mar 06;19(9):null
pubmed: 24626208
Euro Surveill. 2014 Mar 20;19(11):null
pubmed: 24679719
Lancet Respir Med. 2014 Apr;2(4):285-292
pubmed: 24717625
J Clin Microbiol. 2014 Jul;52(7):2479-86
pubmed: 24789177
Nat Commun. 2014 Sep 01;5:4812
pubmed: 25176035
Clin Microbiol Infect. 2015 Mar;21(3):249.e1-9
pubmed: 25614157
Elife. 2015 Mar 03;4:null
pubmed: 25732036
Curr Biol. 2015 Dec 21;25(24):3260-6
pubmed: 26687624
J Clin Microbiol. 2016 Mar;54(3):779-81
pubmed: 26719445
PLoS One. 2016 Apr 15;11(4):e0153668
pubmed: 27082745
J Clin Microbiol. 2016 Jul;54(7):1862-1870
pubmed: 27194683
J Clin Microbiol. 2016 Dec;54(12):2969-2974
pubmed: 27682128
PLoS One. 2016 Oct 17;11(10):e0164736
pubmed: 27749904
Clin Microbiol Infect. 2017 Mar;23(3):161-166
pubmed: 27789378
Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S252-S253
pubmed: 28043590
Euro Surveill. 2017 Jan 12;22(2):
pubmed: 28106529
J Infect Dis. 2017 Aug 1;216(3):366-374
pubmed: 28666374
PLoS One. 2017 Nov 1;12(11):e0186956
pubmed: 29091913

Auteurs

Estefanía Abascal (E)

Servicio Microbiología Clínica y Enfermedades Infecciosas, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
These authors have contributed equally.

Laura Pérez-Lago (L)

Servicio Microbiología Clínica y Enfermedades Infecciosas, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
These authors have contributed equally.

Miguel Martínez-Lirola (M)

Complejo Hospitalario Torrecárdenas, Almería, Spain.

Álvaro Chiner-Oms (Á)

Unidad Mixta Genómica y Salud, Centro Superior de Investigación en Salud Pública (FISABIO)-Universitat de València, Valencia, Spain.

Marta Herranz (M)

Servicio Microbiología Clínica y Enfermedades Infecciosas, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
CIBER Enfermedades respiratorias (CIBERES), Spain.

Imane Chaoui (I)

Unité de Biologie et Recherches Médicales, Division des Sciences du Vivant, Centre National de l'Energie, des Sciences et des Techniques Nucléaires (CNESTEN), Rabat, Morocco.

Iñaki Comas (I)

Instituto de Biomedicina de Valencia (IBV) Consejo Superior de Investigaciones Científicas (CSIC), Valencia, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), Spain.

My Driss El Messaoudi (MD)

Institut Pasteur of Morocco, Casablanca, Morocco.

José Antonio Garrido Cárdenas (JAG)

Servicio de Secuenciación, Universidad de Almería, Almería, Spain.

Sheila Santantón (S)

Servicio Microbiología Clínica y Enfermedades Infecciosas, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.

Emilio Bouza (E)

Servicio Microbiología Clínica y Enfermedades Infecciosas, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Departamento de Medicina, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain.
Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
CIBER Enfermedades respiratorias (CIBERES), Spain.

Darío García-de-Viedma (D)

Servicio Microbiología Clínica y Enfermedades Infecciosas, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
CIBER Enfermedades respiratorias (CIBERES), Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH